Long-Term Outcomes The synergistic effect of GLP-1 agonists with lifestyle changes leads to improved long-term outcomes: Sustained Weight Loss: Individuals who incorporate both dietary modifications and regular exercise while on GLP-1 therapy are more likely to maintain their weight loss over time
Although retatrutide has shown substantial weight-loss efficacy in adults with obesity, the relative contributions of reduced appetite, altered food reward, enhanced energy expenditure, and glucagon-related metabolic effects remain incompletely understood (109)
R., Burlina, A
Valladares R, Sankar D, Li N, Williams E, Lai KK, Abdelgeliel AS, Gonzalez CF, Wasserfall CH, Larkin J, Schatz D, Atkinson MA, Triplett EW, Neu J, Lorca GL (2010) Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats